Contribution of change in glycosylated haemoglobin to insulin-associated weight gain: Results of a longitudinal study in type 2 diabetic patients

Endocrine

Volumn 39, Issue 2, 2011, Pages 190-197

  Jansen, H J ^a   Hendriks, J C ^a   De Galan, B E ^a   Penders, G ^a   Tack, C J ^a   Vervoort, G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Insulin therapy; Type 2 diabetes mellitus; Weight gain

Indexed keywords

HEMOGLOBIN A1C; INSULIN ASPART; ISOPHANE INSULIN;

ADULT; AGED; ARTICLE; BODY WEIGHT; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN TREATMENT; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ASSESSMENT; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 79953660746     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-010-9423-4     Document Type: Article

References (22)

1. R.C. Turner, C.A. Cull, V. Frighi, R.R. Holman, Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281, 2005-2012 (1999)
2. S. Makimattila, K. Nikkila, H. Yki-Jarvinen, Causes of weight gain during insulin therapy with and without metformin in patients with type II diabetes mellitus. Diabetologia 42, 406-412 (1999)
3. M.E. Hickey, T.R. Hall, Insulin therapy and weight change in Native-American NIDDM patients. Diabetes Care 16, 364-368 (1993)
4. J.Q. Purnell, J.E. Hokanson, S.M. Marcovina, M.W. Steffes, P.A. Cleary, J.D. Brunzell, Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial. JAMA 280, 140-146 (1998)
5. D.A. McCarron, M.E. Reusser, Body weight and blood pressure regulation. Am. J. Clin. Nutr. 63, 423S-425S (1996)
6. S.E. Kahn, B. Zinman, S.M. Haffner et al., Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 55, 2357-2364 (2006)
7. H. Yki-Jarvinen, L. Ryysy, M. Kauppila et al., Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 82, 4037-4043 (1997)
8. A. Salle, M. Ryan, G. Guilloteau, B. Bouhanick, G. Berrut, P. Ritz, 'Glucose control-related' and 'non-glucose control-related' effects of insulin on weight gain in newly insulin-treated type 2 diabetic patients. Br. J. Nutr. 94, 931-937 (2005)
9. S. Heller, Weight gain during insulin therapy in patients with type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 65(Suppl 1), S23-S27 (2004)
10. A.N. Jacob, K. Salinas, B. ms-Huet, P. Raskin, Weight gain in type 2 diabetes mellitus. Diabetes Obes. Metab. 9, 386-393 (2007)
11. R.R. Holman, K.I. Thorne, A.J. Farmer et al., Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N. Engl. J. Med. 357, 1716-1730 (2007)
12. G. Verbeke, G. Molenberghs, Linear mixed models in practice: a SAS-oriented approach (Springer-Verlag, New York, 1997)
13. R.R. Holman, A.J. Farmer, M.J. Davies et al., Three-year efficacy of complex insulin regimens in type 2 diabetes. N. Engl. J. Med. 361, 1736-1747 (2009)
14. D.S. Lasserson, P. Glasziou, R. Perera, R.R. Holman, A.J. Farmer, Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses. Diabetologia 52, 1990-2000 (2009)
15. R.A. DeFronzo, Insulin and renal sodium handling: clinical implications. Int. J. Obes. 5(suppl 1), 93-104 (1981)
16. R.R. Wolfe, Effects of insulin on muscle tissue. Curr. Opin. Clin. Nutr. Metab. Care 3, 67-71 (2000)
17. J. Rodin, J. Wack, E. Ferrannini, R.A. DeFronzo, Effect of insulin and glucose on feeding behavior. Metabolism 34, 826-831 (1985)
18. R. Gougeon, M. Lamarche, J.F. Yale, T. Venuta, The prediction of resting energy expenditure in type 2 diabetes mellitus is improved by factoring for glycemia. Int. J. Obes. Relat. Metab. Disord. 26, 1547-1552 (2002)
19. H.U. Janka, G. Plewe, M.C. Riddle, C. Kliebe-Frisch, M.A. Schweitzer, H. Yki-Jarvinen, Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. Diabetes Care 28, 254-259 (2005)
20. The DCCT Research Group, Weight gain associated with intensive therapy in the diabetes control, complications trial. Diabetes Care 11, 567-573 (1988)
21. G. Biesenbach, A. Raml, N. Alsaraji, Weight gain and insulin requirement in type 2 diabetic patients during the first year after initiating insulin therapy dependent on baseline BMI. Diabetes Obes. Metab. 8, 669-673 (2006)
22. UK Prospective Diabetes Study (UKPDS) Group, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment, risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837-853 (1998)